2025 annual financial data
enGene Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -123,165,000 USD and net income was -117,302,000 USD.
Operating cash flow was -99,239,000 USD.
Get free enGene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -123,165,000 USD
- Net income
- -117,302,000 USD
- Operating cash flow
- -99,239,000 USD